Public list: 2017 Game Changers (36) Game Changers 2016 (36) Synthetic Biology (136) Pharma Startups (4733) Animal Health Startups (175)
Caribou Biosciences is a developer of cellular engineering and analysis solutions based on CRISPR technologies, which provide enhanced capabilities to therapeutic development, agricultural biotechnology, industrial biotechnology, and basic and applie...Show all
Company (Alive / Active)
Phone: 510-982-6030
2929 7th Street
Suite 105
Berkeley, 94710
California, United States
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Name | Firm |
|---|---|
| Login to see details | Anterra Capital |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Engineered nucleic acid-targeting nucleic acids | Sep 14, 2017 | May 15, 2018 | Patent |
| Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides | Jul 31, 2017 | May 15, 2018 | Patent |
| Compositions and methods of engineered crispr-cas9 systems using split-nexus cas9-associated polynucleotides | Jul 31, 2017 | May 15, 2018 | Patent |
| Methods for increasing cas9-mediated engineering efficiency | Aug 26, 2015 | May 15, 2018 | Patent |
| Cells comprising engineered nucleic-acid targeting nucleic acids | Oct 18, 2017 | May 01, 2018 | Patent |
Download PDF